Teva Pharmaceutical Industries (TEVA) Cash from Investing Activities Growth (3y) (2020 - 2026)

Teva Pharmaceutical Industries (TEVA) Cash from Investing Activities Growth (3y) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 39.52 Bn 35.79 Bn 1.97 Bn 8.16%
2 Zoetis 33.53 Bn 31.59 Bn 1.62 Bn 26.15%
3 United Therapeutics 23.92 Bn 21.77 Bn 648.10 Mn 75.05%
4 Aurora Cannabis 16.96 Bn 16.88 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.47 Bn 15.15 Bn 800.70 Mn -129.09%
6 Elanco Animal Health 11.76 Bn 11.33 Bn 785.00 Mn -2.94%
7 Alkermes 7.11 Bn 6.60 Bn -116.06 Mn -212.48%
8 Lantheus Holdings 6.53 Bn 6.03 Bn 230.92 Mn 37.22%
9 Hims & Hers Health 5.98 Bn 5.23 Bn 396.79 Mn -55.44%
10 Liquidia 5.44 Bn 5.22 Bn 121.79 Mn -98.10%

Historic Data

Download Data
DateValue
Mar 31, 2026 8.16%
Dec 31, 2025 -0.60%
Sep 30, 2025 -2.80%
Jun 30, 2025 9.65%
Mar 31, 2025 7.68%
Dec 31, 2024 -6.36%
Sep 30, 2024 -2.37%
Jun 30, 2024 -28.21%
Mar 31, 2024 -34.31%
Dec 31, 2023 28.76%
Sep 30, 2023 5.43%
Jun 30, 2023 -1.19%
Mar 31, 2023 -10.44%
Dec 31, 2022 -26.90%
Sep 30, 2022 -13.10%
Jun 30, 2022 -25.28%
Mar 31, 2022 -16.04%
Dec 31, 2021 49.25%
Sep 30, 2021 -6.02%
Jun 30, 2021 5.81%